Research Faculty

Nancy E Adler, PhD

Research Areas: Socioeconomic influences on health, reproductive health and population health

Patricia A. Areán, PhD

Research Areas: efficacy/effectiveness of psychotherapy in later life, increasing access to mental health services in, low-income and minority elderly

Kirstin Aschbacher, PhD

Research Areas:

Deborah E. Barnes, PhD, MPH

Research Areas: Identification of factors that may protect against dementia and other geriatric neuropsychiatric disorders.

Samuel Barondes, MD

Research Areas: Psychopharmacology and psychiatric genetics.

William Byerley, MD

Research Areas: Molecular genetic studies of schizophrenia and Manic Depressive Disorder

Ben Cheyette, MD, PhD

Research Areas: wnt signaling and behavior, wnt signaling and brain development, intercellular signaling in brain function and molecular components of psychiatric disorders

Kevin L. Delucchi, PhD

Research Areas: statistics, drug abuse, alcohol, clinical trials

James W. Dilley, MD

Research Areas: For the past 20 years, I have had a professional interest in the mental health aspects of the HIV epidemic. I have been interested both in understanding the mental health consequences of HIV infection as well as in bringing a mental health perspective to the critical task of preventing the sexual transmission of HIV. In addition, as an administrator and the Director of the UCSF AIDS Health Project, the largest HIV and mental health services organization in San Francisco, I have an ongoing interest in service delivery and program evaluation. To those ends, I have pursued several research activities in each of these areas (see above).

Allison J. Doupe, MD, PhD

Research Areas:

Laura Dunn, MD

Research Areas: Geriatric psychiatry, empirical ethics, research ethics, bioethics, decision making, capacity, competency, informed consent, psychooncology, schizophrenia, dementia, residency education, medical education

Stuart J. Eisendrath, MD

Research Areas: depression and factitious disorders

Elissa S. Epel, PhD

Research Areas: cell aging, psychoneuroendocrinology, stress and coping, insulin resistant syndrome (aka Metabolic Syndrome)

Judith Ford, PhD

Research Areas: brain imaging (fMRI and EEG) in schizophrenia

Sharon M. Hall, PhD

Research Areas: behavioral and pharmacological treatment of substance abuse

Robert Hendren, DO

Research Areas: Primary areas of research and publication interests are translational clinical pharmacology and nutritional trials using biomarkers (MRI, measures of inflammation, oxidative stress, immune function and pharmacogenomics) in neurodevelopmental disorders.

Fumiko Hoeft, MD, PhD

Research Areas: Genetic and behavioral influences on children's brain development; investigation of neuroimaging as a biomarker; brain basis of neurodevelopment and its disorders; development of training and intervention paradigms to enhance and remediate cognitive functions.

Other Titles:
Research Scientist, Haskins Laboratory, Yale University
Visiting Associate Professor, Department of Psychiatry, Stanford University School of Medicine
Adjunct Lecturer, Department of Neuropsychiatry, Keio University School of Medicine

Mardi J. Horowitz, MD

Research Areas:

Impact of stress, loss, defense mechanisms, identity and person-schematic change processes.


Grieving As Well As Possible by Mardi Horowitz, MD

 Grieving As Well As Possible

This recent release from Dr. Horowitz contains practical advice for people who have sustained a serious loss, including the death of a loved one, divorce, loss of a home, or sudden disability, and for those close to them. Arranged sequentially in terms of expectable reactions, the book is illustrated with thought provoking and inspiring stories, including his own, which show what "as well as possible" can mean to the reader.

Stress Response Syndromes, Fifth Edition Stress, Response Syndromes:
PTSD, Grief, Adjustment, and Dissociative Disorders

Dr. Horowitz's book, Stress Response Syndromes: PTSD, Grief, Adjustment, and Dissociative Disorders, has been released in a revised fifth edition.The classic first edition contributed to establishing post traumatic stress disorder as a diagnosis.

Dr. Horowitz's other books include Assessment Based Treatment for PTSD, and A Course in Happiness, which examines the mastery of stress as a route towards greater contentment.

Gary Humfleet, PhD

Research Areas: substance abuse treatment with emphasis on nicotine dependence, LGBT health issues, HIV, substance abuse treatment, clinical trials methology, internet-based interventions

Reese T. Jones, MD

Research Areas:

Nick Kanas, MD

Research Areas:

For more than 30 years, Dr. Kanas has studied the psychological interactions of people under stress and ways they can cope better with stressors in their environment. His earlier work involved groups of veteran patients suffering from alcoholism, PTSD, and schizophrenia. For over 12 years, he has studied astronauts living and working in space. He has been the Principal Investigator of two large NASA-funded international studies involving the Mir and International Space Stations, and he currently is the Principal Investigator of a NASA-funded study aimed at training astronauts to deal with psychological stressors in space. In 1999, Dr. Kanas received the Aerospace Medical Association Raymond F. Longacre Award for Outstanding Accomplishment in the Psychological and Psychiatric Aspects of Aerospace Medicine. In 2003, Dr. Kanas received the J. Elliott Royer Award for excellence in Academic Psychiatry. Dr. Kanas is the co-author of a book entitled Space Psychology and Psychiatry, which was the recipient of the 2004 International Academy of Astronautics Life Sciences Book Award.

Margaret Kemeny, PhD

Research Areas: psychoneuroimmunology; relationship between psychological factors, neurophysiological mechanisms and disease processes, particularly in HIV-1 and inflammatory diseases; effects of cognitive representations on emotion, physiology and health; threats to social status and their effects on cognitive representations of the self and self-conscious emotions including shame, as well as the hypothalamic pituitary adrenal axis and the cytokine network, particularly pro-inflammatory cytokines and cognitive representations of future health and their physiological correlates and health consequences; the role of expectancies in the effects of placebos on inflammatory processes

Kaja LeWinn, DSc

Research Areas:

Alicia F. Lieberman, PhD

Research Areas: mental health problems and traumatic stress responses in infancy and early childhood; attachment disorders, parenting problems in the birth-to-five age range, treatment outcome research to close the gap in evidence-based treatment for minority young children and their families

Rachel Loewy, PhD

Research Areas: Schizophrenia; prodromal psychosis; recent-onset psychosis; transitional age youth; clinical assessment; community partnerships

Scott Mackin, PhD

Research Areas:

The assessment of cognitive functioning pre and post treatment; identifying cognitive phenotypes of psychiatric disorders; identifying neuropsychiatric symptoms of underlying neurodegenerative disease in older adults; evaluating the ipact of cognitive impairment and depression on functional status; training on the use and interpretation of cognitive screening tools

Christina Mangurian, MD

Research Areas: mental health services research, schizophrenia, metabolic effects of antipsychotic medications, health disparities research.

Carmen L. Masson, PhD

Research Areas: drug abuse and HIV prevention, health services research and nicotine dependence

Daniel Mathalon, PhD, MD

Research Areas: Functional MRI and EEG/event-related potential studies of schizophrenia, including prodromal period prior to illness onset.  Focus on neural correlates of sensory, perceptual, cognitive and clinical symptoms of psychosis.

Carol A. Mathews, MD

Research Areas: psychiatric genetics, epidemiology and etiology of OCD, TS, HD, and related neuropsychiatric disorders, phenotype-genotype correlations, endophenotypes, and phenomenology

Keith McBurnett, PhD

Research Areas: hormonal factors in disruptive behavior disorders, developmental psychopathology, classification and treatment outcome

Wendy Berry Mendes, PhD

Research Areas: Emotion, health, intergroup relations, interpersonal processes, prejudice/stereotyping

Thomas C. Neylan, MD

Research Areas:

PTSD neurobiology and treatment research, sleep-wake physiology, daytime fatigue and performance, neuroendocrinology, gene microarray, brain imaging, and Phase II & III clinical trials.

Aoife O'Donovan, MPsychSc, PhD

Research Areas:

Linda J. Pfiffner, PhD

Research Areas: treatment outcome for ADHD and related disruptive behavior problems, development of integrated home-school interventions for ADHD-Inattentive Type and the role of family factors in developmental models of child psychopathology

Victor I. Reus, MD

Research Areas: behavioral endocrinology, particularly endocrine effects of stress and behavioral effects of CRF, ACTH and glucocorticoids, genetics of bipolar mood disorder, genetics of Tourette Disorder; pharmacogenetics and psychopharmacology

S. Craig Risch, MD

Research Areas: treatment refractory mood disorders and psychoses; multicenter psychopharm clinical trials; investigator initiated psychopharm clinical

Demian Rose, MD, PhD

Research Areas: Early psychosis, clinical outcome measures, psychotherapy for psychosis

Abram Rosenblatt, PhD

Research Areas: children’s mental health services research, juvenile justice and children’s mental health and public policy research and children’s service systems

John L.R. Rubenstein, MD, PhD

Research Areas: development of the forebrain

Derek D. Satre, PhD

Research Areas: alcohol and drug treatment services research, treatment access, effects of drinking on health, psychotherapy, psychiatric comorbidity

Martha Shumway, PhD

Research Areas: Mental health services research, measurement, preference/utility assessment, cost-effectiveness analysis, schizophrenia, research design, data analysis, mixed methods research, cognition, trauma, posttraumatic stress disorder, co-occuring conditions, psychiatric and medical emergency services, involuntary treatment, public sector care, underserved populations

Vikaas Singh Sohal, MD, PhD

Research Areas: Our laboratory conducts basic science research about how microcircuits in the prefrontal cortex process information, and how this may be disrupted in psychiatric diseases such as schizophrenia.  We combine several techniques including brain slice electrophysiology, cell-type specific optogenetic stimulation using channelrhodopsin, in vivo recording, behavioral assays, computational modeling, and information theory.

James L. Sorensen, PhD

Research Areas: substance abuse & mental health, prevention and treatment of AIDS and other infectious diseases

Laurence H. Tecott, MD, PhD

Research Areas: molecular genetics of serotonin system regulation of behavior

Jeanne M. Tschann, PhD

Research Areas: family relationships and adolescent functioning, relationship dynamics and condom use among Latino adolescents, obesity among Mexican American children, research with Latino populations

Janice Y. Tsoh, PhD

Research Areas: nicotine dependence treatment in special populations, co-occurring mental and substance use disorders

Sophia Vinogradov, MD

Research Areas: Dr. Vinogradov directs a translational clinical neuroscience laboratory that focuses on cognitive dysfunction in schizophrenia. In collaboration with basic neuroscientist, Michael Merzenich, Ph.D., she studies neuroscience-guided computerized cognitive training exercises for patients with schizophrenia that aim to drive enduring plastic changes in cortical processing. Dr. Vinogradov uses MEG and fMRI methods to probe the brain changes in both early sensory processing and higher-order cognitive operations in subjects who undergo this cognitive training. She is also examining changes in serum biomarkers (BDNF, D-serine) as a response to training. More recently, Dr. Vinogradov has begun to apply these methods to the study of adolescents who are prodromal for schizophrenia and young adults in early psychosis, with the goal of delaying or preventing the onset of a deteriorating psychiatric illness.

Susan M. Voglmaier, MD, PhD

Research Areas: cellular and molecular neurobiology, vesicle trafficking and neurotransmitter release

Mark von Zastrow, MD, PhD

Research Areas: cellular neurobiology, psychopharmacology and drug abuse

Angela E. Waldrop, PhD

Research Areas: PTSD, substance use disorders, risk behaviors including HIV risk

Constance M. Weisner, DrPH, MSW

Research Areas: alcohol and drug epidemiology, access and utilization, treatment outcome and cost effectiveness

Owen M. Wolkowitz, MD

Research Areas: Psychoneuroendocrinology, particularly effects of stress and stress hormones on the brain (glucocorticoids, neurosteroids, neurotropic factors), psychopharmacology of depression and anxiety

Kristine Yaffe, MD

Research Areas:

With primary research goals of understanding the mechanisms that cause cognitive decline, identifying novel risk factors for cognitive impairment, and looking for strategies to prevent and treat cognitive disorders, the group works to improve the outlook of cognitive aging. An additional focus of our group is conceptualization and characterization of Healthy Brain Aging.

Some of our current funded research projects include:

• Determining the how depressive symptoms are associated with cognitive and functional decline over the long term among older women.

• Identifying comprehensive risk factors for mild cognitive impairment and dementia among community-dwelling elderly women in their 9th and 10th decades of life.

• Identifying cognitive trajectories, their predictors and outcomes among elderly men and women in their 9th and 10th decades of life, and determining factors associated with maintaining optimal cognitive function.

• Investigating the association between sleep dysfunction and cognitive impairment in a large prospective study.

• Determining how PTSD and traumatic brain injury contribute to the risk of developing dementia in old age.

• Determining the association between chronic renal insufficiency and cognitive impairment in a large multi-site prospective study.

• Determining the association between behavioral disturbances such as hallucinations, agitation and depression and cognitive decline. We are studying ways to treat these symptoms (both pharmacologically and behaviorally) and trying to understand why they often lead to poor outcomes.

• Assessing whether staying active, either physically or mentally, is a strategy to prevent cognitive decline.

• Investigating how diabetes and other cardiovascular risk factors may contribute to accelerated cognitive aging. 


Leadership in research, education, psychiatric care and public service